We are live on
!
Find out more
Celldex Therapeutics
CLDX
CLDX
140 hedge funds and large institutions have $293M invested in Celldex Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
12% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 42
4.56% more ownership
Funds ownership: 0% → 4.56% (+4.6%)
1% more funds holding
Funds holding: 138 → 140 (+2)
4% more capital invested
Capital invested by funds: $281M → $293M (+$11.2M)
2% more call options, than puts
Call options by funds: $1.88M | Put options by funds: $1.85M
Holders
140
Holders Change
+2
Holders Change %
+1.45%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
47
Reduced
42
Closed
15
Calls
$1.88M
Puts
$1.85M
Net Calls
+$29K
Net Calls Change
+$493K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.1M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$12.5M |
| 3 |
DM
Deerfield Management
New York
|
+$2.4M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.1M |
| 5 |
QI
QS Investors
New York
|
+$1.57M |
Top Sellers
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.02M |
| 2 |
RI
RTW Investments
New York
|
-$3.81M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.95M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.53M |
